Health inequality in COVID-19 vaccination coverage

Journal Title: Health Science Monitor - Year 2023, Vol 2, Issue 1

Abstract

Dear Editor, According to the latest report of World Health Organization,  which was published on November 8, 2021, more than 249,743,428 people were infected with COVID-19 and 5,047,652 people died from  this disease worldwide. Furthermore, more than seven billion doses of vaccine have been used against the COVID-19 pandemic across the world (1). COVID-19 can take two forms including the asymptomatic and symptomatic forms and may cause a wide and varied range of symptoms (2-6). One of the most serious and current human rights is to have access to diagnostic, treatment and vaccination facilities against COVID-19, especially in the poor areas and low-income countries. In addition, vaccination is regarded to be a very important primary preventive measure since it causes a significant reduction in the COVID-19 development, decreases its morbidity, and reduces its mortality rates (7). In fact, health inequality is a comprehensive concept that reflects the differences and inequalities in people's access to health care (8). It is obvious that health-care-access injustice ultimately leads to inequality in health (9). At the beginning of 2021, several COVID-19 vaccines were developed. These vaccines were classified into three categories. The first category involved the RNA messenger vaccines (mRNA) which included Moderna and Pfizer-BioNTech vaccines. The second category comprised the vaccines which were made with the help of human and mammalian adenoviruses such as Spuntink-V, Astera-Zenec, and Johnson & Johnson. Finally, the third category involved the inactivated viral vaccines such as Bharat Biotech, Sinopharm, and Sinovac (10). These vaccines and the new medications have been effective (11). Nonetheless, there are still countries around the world which are not able to purchase the approved vaccines. Moreover, a number of the people, who have access to the vaccines, are not willing to trust a new vaccine. These two issues are major concerns which severely affect the vaccination coverage rate, the break in the disease transmission chain, and the end of the COVID-19 pandemic (12). Finally, it can be stated that the causes of low vaccination coverage include the following factors (13, 14): Lack of access to vaccines Distrust of governments Negative role of national media Poor performance of health personnel Negative role of social and virtual networks Complications of vaccination Low knowledge about the consequences of the COVID-19 among the general population. In conclusion, it can be noted that, the above mentioned factors influence inequality in COVID-19 vaccination coverage. More specifically, the countries have different vaccination coverage rates. Therefore, the consequences of COVID-19 and the general health status are different across the world.

Authors and Affiliations

Mousa Ghelichi-Ghojogh,Rozhan Khezri,Fatemeh Rezaei,Somayeh Aljalili,Rohollah Valizadeh,Tella Sadighpour,

Keywords

Related Articles

Determination of environmental impact and energy recovery from municipal solid wastes in the Northwest of Iran

Background & Aims: Unsuitable management of municipal solid waste (MSW) is one of the main factors in environmental degradation, particularly in developing countries. This study aimed to analyze the quantitative and...

Using a photographic image processing method as a part of the QA program in some radiotherapy departments where CTs are involved with COVID-19 patients

Background & Aims: Owing to the significant role of CT images in diagnosis and follow up of patients affected with coronavirus, the imaging section of cancer centers in some countries engaged in providing services to...

Microscopic alterations in the hepatic architecture of male albino rats following administration of nandrolone decanoate

Background & Aims: The synthetic testosterone analog nandrolone decanoate (ND) is one of the most commonly used anabolic androgenic steroids (AAS) among athletes and teens. Athletes who consume anabolic androgenic st...

Assessing the influence of noise levels on medication errors of nurses in a hospital in Kashan, Iran

Background & Aims: Noise exposure can impact nurses' performance and may result in disruptions to their tasks. This study aimed to examine the correlation between the average equivalent sound level and the occurrence...

Headache as a sign of ear, nose, and throat diseases: evidence from a specialized clinic

Background & Aims: Headache has been a common problem for humans since ancient times. The aim of this study was to investigate the prevalence of ear, nose, and throat diseases in patients with headache. Materials &a...

Download PDF file
  • EP ID EP723571
  • DOI http://dx.doi.org/10.52547/hsm.2.1.10
  • Views 53
  • Downloads 0

How To Cite

Mousa Ghelichi-Ghojogh, Rozhan Khezri, Fatemeh Rezaei, Somayeh Aljalili, Rohollah Valizadeh, Tella Sadighpour, (2023). Health inequality in COVID-19 vaccination coverage. Health Science Monitor, 2(1), -. https://europub.co.uk/articles/-A-723571